Recession-Proof? The Beauty of Big Pharma Is in the Eye of the Beholder [View article]
PFE needs to do a deal, they are lucky they are so big, otherwise theyd be a target for exhibiting such poor use of cash. Stock @ 10 yr low, single digit PE, distressed like div yield, and $26b in cash...they have to pay out a massive div or do deals. AMGN? maybe BIIB maybe? do something!!!! The CEO has a vice grip on the cash and cash cant earn jack returns in this milieu!!!
-
PFE needs to do a deal, they are lucky they are so big, otherwise theyd be a target for exhibiting such poor use of cash. Stock @ 10 yr low, single digit PE, distressed like div yield, and $26b in cash...they have to pay out a massive div or do deals. AMGN? maybe BIIB maybe? do something!!!! The CEO has a vice grip on the cash and cash cant earn jack returns in this milieu!!!
Dec 18 16:23 pm
|Rating:
0
0
All Comments by Dan Jacome »Recession-Proof? The Beauty of Big Pharma Is in the Eye of the Beholder [View article]